Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Review (2021)
Author(s)

Francisco Alves (Universidade de Coimbra)

Inês F. Antunes (University Medical Center Groningen)

Emiliano Cazzola (Sacro Cuore Hospital, Verona)

Frederik Cleeren (Katholieke Universiteit Leuven)

Bart Cornelissen (University Medical Center Groningen)

A. G. Denkova (TU Delft - RST/Applied Radiation & Isotopes)

Jonathan Engle (University of Wisconsin-Madison)

Alain Faivre-Chauvet (ENS-PSL Research University & CNRS)

Yann Seimbille (Erasmus MC)

More authors (External organisation)

Research Group
RST/Applied Radiation & Isotopes
Copyright
© 2021 Francisco Alves, Inês F. Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, A.G. Denkova, Jonathan Engle, Alain Faivre-Chauvet, Y. Seimbille, More Authors
DOI related publication
https://doi.org/10.1186/s41181-021-00146-9
More Info
expand_more
Publication Year
2021
Language
English
Copyright
© 2021 Francisco Alves, Inês F. Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, A.G. Denkova, Jonathan Engle, Alain Faivre-Chauvet, Y. Seimbille, More Authors
Research Group
RST/Applied Radiation & Isotopes
Issue number
1
Volume number
6
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.